CytomX Therapeutics Announces Pricing of $250 Million Offering of Common Stock and Pre-Funded Warrants

Go back to CytomX Therapeutics Announces Pricing of $250 Million Offering of Common Stock and Pre-Funded Warrants
Eaton Vance Dividend Builder Fd Cl C (NASDAQ: CTMX) Delayed: 3.76 -0.19 (4.81%)
Previous Close $3.95    52 Week High $24.68 
Open $4.00    52 Week Low $9.10 
Day High $4.02    P/E N/A 
Day Low $3.62    EPS $0.00 
Volume 2,992,157